Livanova (LIVN) PT Raised to $104 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St futures muted as bond yields resume climb; Walmart drops after results
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
LivaNova Reports Fourth Quarter and Full-Year 2017 Results
February 28, 2018 7:01 AM ESTLONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today reported results for the quarter and full-year ended December 31, 2017.
For the fourth quarter of 2017, worldwide sales from continuing operations were $278.4 million, an increase of 11.5 percent on a reported basis and an increase of 8.1 percent on a constant currency basis, as compared to the same quarter of the previous year. On the basis of U.S. Generally Accepted Accounting Principles ("GAAP"), fourth quarter 2017 diluted losses per share from continuing operations were ($0.65). Fourth quarter 2017 adjusted diluted earnings per... More
